As the race to deliver personalised engagement at scale gains pace, artificial intelligence (AI) has become a critical differentiator for pharma companies.
In 2020, commercial leadership at EVERSANA, well versed in the transformation of the contract research organisation (CRO) sector, believed that the often slow-to-pivot pharmaceutical indust
In this issue, we delve into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and
To encourage the uptake of complex therapies in clinical practice, brand teams must ensure they use data-driven insights to understand the needs and preferences of healthcare professionals
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl